These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36000917)

  • 21. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Ratio of Urine N-Terminal Pro B-Type Natriuretic Peptide to Cyclic Guanosine Monophosphate Predicts Emergency Department Visits for Heart Failure.
    Chen JY; Lee SY; Shieh MD
    Cardiology; 2022; 147(5-6):539-546. PubMed ID: 36223720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino-Terminal Pro-B-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Renal Dysfunction: A Systematic Review and Meta-Analysis.
    Schaub JA; Coca SG; Moledina DG; Gentry M; Testani JM; Parikh CR
    JACC Heart Fail; 2015 Dec; 3(12):977-89. PubMed ID: 26671676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood Biomarker Panels for the Early Prediction of Stroke-Associated Complications.
    Faura J; Bustamante A; Reverté S; García-Berrocoso T; Millán M; Castellanos M; Lara-Rodríguez B; Zaragoza J; Ventura O; Hernández-Pérez M; van Eendenburg C; Cardona P; López-Cancio E; Cánovas D; Serena J; Rubiera M; Dávalos A; Montaner J
    J Am Heart Assoc; 2021 Feb; 10(5):e018946. PubMed ID: 33634708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure.
    De Berardinis B; Gaggin HK; Magrini L; Belcher A; Zancla B; Femia A; Simon M; Motiwala S; Bhardwaj A; Parry BA; Nagurney JT; Coudriou C; Legrand M; Sadoune M; Di Somma S; Januzzi JL;
    Clin Chem Lab Med; 2015 Mar; 53(4):613-21. PubMed ID: 25473804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.
    Noveanu M; Breidthardt T; Potocki M; Reichlin T; Twerenbold R; Uthoff H; Socrates T; Arenja N; Reiter M; Meissner J; Heinisch C; Stalder S; Mueller C
    Crit Care; 2011; 15(1):R1. PubMed ID: 21208408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
    Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
    Eur J Heart Fail; 2015 Sep; 17(9):936-44. PubMed ID: 26222618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F
    J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure.
    Ma X; Chen Y; Reginauld SH; Scott CG; Iyer SR; Schaefer JJ; Ichiki T; Chen HH; Rule AD; Burnett JC; Sangaralingham SJ
    JACC Heart Fail; 2021 Sep; 9(9):613-623. PubMed ID: 34246604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal prohormone B-type natriuretic peptide variability acts as a predictor of poor prognosis in patients with cardiorenal syndrome type 2.
    Ma M; Luo Q; Dong X; Cui S; Hocher B; Zeng S; Liang W; Li Q; Chen X; Chen X; Meng Y; Lu Y; Yang D; Yin L
    Bioengineered; 2021 Dec; 12(2):12407-12419. PubMed ID: 34905428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung ultrasound integrated with clinical assessment for the diagnosis of acute decompensated heart failure in the emergency department: a randomized controlled trial.
    Pivetta E; Goffi A; Nazerian P; Castagno D; Tozzetti C; Tizzani P; Tizzani M; Porrino G; Ferreri E; Busso V; Morello F; Paglieri C; Masoero M; Cassine E; Bovaro F; Grifoni S; Maule MM; Lupia E;
    Eur J Heart Fail; 2019 Jun; 21(6):754-766. PubMed ID: 30690825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
    Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
    Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure.
    Yoon JY; Yang DH; Cho HJ; Kim NK; Kim CY; Son J; Roh JH; Jang SY; Bae MH; Lee JH; Park HS; Cho Y; Chae SC
    Korean J Intern Med; 2019 Jul; 34(4):811-818. PubMed ID: 30616330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
    Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE
    Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino-terminal pro-B-type natriuretic peptide, inferior vena cava ultrasound, and biolectrical impedance analysis for the diagnosis of acute decompensated CHF.
    Gil Martínez P; Mesado Martínez D; Curbelo García J; Cadiñanos Loidi J
    Am J Emerg Med; 2016 Sep; 34(9):1817-22. PubMed ID: 27396536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of Amino-Terminal Pro- BNP , Estimated GFR , and High-Sensitivity CRP for Predicting Cardiorenal Syndrome Type 1 in Acute Myocardial Infarction Patients.
    Zhang DQ; Li HW; Chen HP; Ma Q; Chen H; Xing YL; Zhao XQ
    J Am Heart Assoc; 2018 Oct; 7(19):e009162. PubMed ID: 30371311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Terminal B-type Natriuretic Peptide in Heart Failure.
    Richards AM
    Heart Fail Clin; 2018 Jan; 14(1):27-39. PubMed ID: 29153198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predictive value of admission amino-terminal pro-B-type natriuretic peptide on in-hospital mortality in patients with decompensated heart failure].
    Wei BQ; Yang YJ; Zhang J; Dou KF; Zhang YH; Huang XH; Kang LM; Zhang CL; Gu Q; Gao X; Yang YM; Dai Y; Yu LT; Zhang HM; Lü R
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):481-5. PubMed ID: 19927625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of quantitative capnometry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital emergency setting: study of diagnostic accuracy.
    Klemen P; Golub M; Grmec S
    Croat Med J; 2009 Apr; 50(2):133-42. PubMed ID: 19399946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.
    Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
    JACC Heart Fail; 2016 Sep; 4(9):736-45. PubMed ID: 27395353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.